Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study

N Reesink-Peters, B M T Hougardy, F A J van den Heuvel, K A Ten Hoor, H Hollema, H M Boezen, E. G. E. de Vries, S de Jong, A G J van der Zee

Research output: Contribution to journalArticleAcademicpeer-review

64 Citations (Scopus)

Abstract

OBJECTIVE: Increasing imbalance between proliferation and apoptosis is important in cervical carcinogenesis. The death ligands FasL and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induce apoptosis by binding to their cognate cell-surface death receptors Fas or death receptor (DR) 4 and DR5. This study aims to examine if changes in death ligand and death receptor expression during different stages of cervical carcinogenesis are related to an imbalance between proliferation and apoptosis.

METHODS: The immunohistochemical expression and localization of Fas/FasL and DR4/DR5/TRAIL were assessed in 11 normal cervices, 15 cervical intraepithelial neoplasia (CIN) grade I, 15 CIN II, 13 CIN III, and 25 (microinvasive) squamous cell cervical cancers. The number of apoptotic cells was determined by morphological criteria and the number of proliferating cells by counting Ki-67-positive cells.

RESULTS: A marked increase in proliferation as well as apoptosis percentage was found with increasing severity of neoplasia. In normal cervix and CIN I samples, FasL, DR4, DR5, and TRAIL staining was mainly observed in the basal/parabasal layer, whereas Fas staining was localized in the superficial, more differentiated epithelial layer. Frequency of Fas-positive staining decreased with increasing severity of CIN. In contrast, homogeneous FasL, DR4, DR5, and TRAIL expression throughout the lesions was more frequently observed in CIN III and cervical cancer. FasL, DR4, DR5, and TRAIL staining patterns were correlated, although TRAIL expression was more intense in low-grade lesions. No association was found between death receptor or ligand expression with the percentage of apoptosis or proliferation.

CONCLUSION: The loss of Fas and the deregulation of FasL, DR4, DR5, and TRAIL in the CIN-cervical cancer sequence suggest a possible functional role of these death ligands and receptors during cervical carcinogenesis. The frequent expression of DR4 and DR5 presents these receptors as promising targets for innovative therapy modalities in cervical cancer.

Original languageEnglish
Pages (from-to)705-713
Number of pages9
JournalGynecologic Oncology
Volume96
Issue number3
DOIs
Publication statusPublished - Mar-2005

Keywords

  • cervical cancer
  • CIN
  • Fas
  • FasL
  • DR4
  • DR5
  • TRAIL
  • apoptosis
  • proliferation
  • immunohistochemistry
  • APOPTOSIS-INDUCING LIGAND
  • TRAIL-INDUCED APOPTOSIS
  • DECOY RECEPTOR
  • TARGETING DEATH
  • CANCER-THERAPY
  • FAS LIGAND
  • EXPRESSION
  • CELLS
  • CARCINOMA
  • ADENOMAS

Cite this